Latest Infliximab Stories
Three separate studies presented today at the American College of Gastroenterology's (ACG) 77th Annual Scientific meeting in Las Vegas help to advance understanding of the differences between African American and Caucasian patients with Inflammatory Bowel Disease (IBD) and provide clinicians with new insight on how racial disparities involving disease characteristics, infliximab use, and fistulizing Crohn's disease may impact their patients—and their decisions on how best to manage the...
Researchers at Emory University have found that a medication that inhibits inflammation may offer new hope for people with difficult-to-treat depression.
People suffering from ulcerative colitis may be getting some new relief due to a decision by the Food and Drug Administration (FDA) to open a new drug to help alleviate symptoms.
An investigational drug currently under FDA review for the treatment of rheumatoid arthritis has now shown positive results in patients with moderate-to-severe ulcerative colitis.
New research confirms no significant difference in the rates of death among patients with rheumatoid arthritis (RA) who were exposed to one of several TNF inhibitors used to treat RA, adalimumab (Humira), etanercept (Enbrel), and infliximab (Remicade).